Physician Research Collaboration, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis3 trials
• Coronary artery disease1 trial
• Obesity1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Vitiligo1 trial

Phase

• Phase 35 trials
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Alfasigma S.p.A.1 trial
• Amgen1 trial
• Pfizer1 trial
• SetPoint Medical Corporation1 trial

Running trials

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

• Active, not recruiting

  Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

  NCT04539964· Phase 3· SetPoint Medical Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting

Closed trials

• Completed

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

  NCT06588296· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

  NCT03915964· Phase 4· Eli Lilly and Company· Source

• Completed

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· Phase 3· Alfasigma S.p.A.· Source